Searched for
INFLUENZA VACCINE DEMAND
Kolkata hospitals report sharp rise in pneumonia & flu vaccination; Experts urge elderly to get protected immediatelyKolkata is experiencing a significant surge in demand for pneumonia and influenza vaccines. Respiratory infections are climbing as winter a...- China's Ab&B Bio-Tech shares soar 170% driven by retail demandAb&B Bio-Tech, a Chinese vaccine firm, witnessed a remarkable stock market debut in Hong Kong. Shares soared almost 170% after its initial ...
- Health Secretary RFK Jr. overrules scientists, bans Thimerosal vaccine preservative tied to autism claimsUS Health and Human Services Secretary Robert F. Kennedy Jr. has banned thimerosal from US vaccines, despite scientific evidence of its saf...
- H5N1 virus in US sparks global health crisis: Know its symptoms, mode of transmission, vaccineH5N1 avian influenza virus: The spread of H5N1 avian influenza virus in the United States has sparked fears of a potential pandemic. The H5...
- Panacea Biotec gets $20 million loan from US government for hexavalent vaccine capacity expansionPanacea Biotec has secured a $20 million long-term loan from the US International Development Finance Corporation to expand its hexavalent ...
- China says there is no detection of 'unusual or novel pathogens' in surge of respiratory illnesses: WHOChina responded to the World Health Organization's call for information on rising child respiratory illnesses. Denying unusual pathogens, C...
- Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts sayModerna, the COVID-19 vaccine manufacturer, is poised to meet its 2023 sales target as it taps into the private market. Analysts suggest th...
- You may not need a fourth Covid vaccine now but a flu shotPublic health experts suggest that a fourth dose of the Covid vaccine is unnecessary for now. With only 220 million people taking the third...
- Sanofi to let go of staff at vaccine plants in India as part of reviewThe drugmaker is offering voluntary retirement scheme (VRS) to all its employees at two sites near Hyderabad, a spokesperson for Sanofi's I...
- Covid vaccine a shot in the arm for these 10 stocksVoltas and Blue Star have rallied 66 per cent each in the last six months while logistics companies have gained between 30 per cent and 90 ...
- Top stocks to play the vaccine themeBlue Star, Voltas, Snowman, Blue Dart, Allcargo, and SpiceJet are among the companies that will be as crucial to public health in the immed...
- Sanofi to enroll thousands for its coronavirus vaccine trialsSanofi is working on two vaccine projects to prevent COVID-19 - the illness caused by the new coronavirus - and said it is exploring severa...
- Indian companies among emerging world's vaccine heroes: Bill GatesGates, the founder of Microsoft, is co-chair of the Bill & Melinda Gates Foundation.
- Easyfive TT vaccine to be back in WHO list: Panacea BiotecPanacea Biotec is hopeful of resuming supplies of its pentavalent vaccine 'Easyfive TT', which prevents Tetanus and Hepatitis B.
- Agreement with Biological E to lower cost of vaccine: GAVIGAVI Alliance was created in 2000 to accelerate the introduction of new vaccines so that all children.
- Sanofi expects 50 pc Indian market share for flu vaccinesThe co today launched 'Mothers Against Flu', a facebook community of mothers. The company has roped in actress Raveena Tandon for the campa...
- India emerging as leading vaccine manufacturer: Steven MyintIndia had revenue of $ 665 million in this space which was expected to reach $ 800 million soon, said Steven H Myint.
- Zydus Cadila gets DCGI nod to conduct trials for H1N1 vaccineDrug maker Zydus Cadila on Monday said it has received approval from the Drug Controller General of India (DCGI) for conducting clinical tr...
- WHO sees boost in flu pandemic vaccine productionThe World Health Organisation today said that recent scientific advances should boost production capacity of pandemic flu vaccines to 4.5 b...
- Sanofi arm may make India global output hub for vaccinesIndia may be a possible location as a global manufacturing base for vaccines business of Sanofi-Aventis Group.
Load More
